Navigating COVID-19 Testing: Special Considerations for the Cardiovascular Clinician

Palak Shah; Christopher R deFilippi; Kristin E Mullins

doi:10.1161/CIRCULATIONAHA.120.051183

Navigating COVID-19 Testing: Special Considerations for the Cardiovascular Clinician

Circulation. 2020 Dec 15;142(24):2293-2295. doi: 10.1161/CIRCULATIONAHA.120.051183. Epub 2020 Oct 16.

Authors

Palak Shah¹, Christopher R deFilippi², Kristin E Mullins³

Affiliations

¹ Cardiovascular Genomics Center, Heart Failure and Transplantation (P.S.), Inova Heart and Vascular Institute, Falls Church, VA.
² Cardiovascular Medicine (C.R.d.F.), Inova Heart and Vascular Institute, Falls Church, VA.
³ Department of Pathology, University of Maryland School of Medicine, Baltimore (K.E.M.).

No abstract available

Keywords: COVID-19 diagnostic testing; cardiovascular disease; high-throughput DNA sequencing; nucleic acid amplification techniques; polymerase chain reaction.

Publication types

Research Support, N.I.H., Extramural
Review

MeSH terms

COVID-19 / diagnosis*
Cardiovascular Diseases / virology
Humans
Molecular Diagnostic Techniques
Nucleic Acid Amplification Techniques / methods
Physician's Role*
Reverse Transcriptase Polymerase Chain Reaction* / methods
Sensitivity and Specificity*

Publication types

MeSH terms

Grants and funding